Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study
The serum creatinine-cystatin C ratio is an independent predictor of 1-year mortality risk in advanced breast cancer, with higher levels associated with significantly reduced mortality.
Authors
- Robert H. Deng (ORCID: https://orcid.org/0000-0003-3491-8146)
- Guanyu Zheng (ORCID: https://orcid.org/0000-0002-0940-0559)
- Yuanqi Zhang (ORCID: https://orcid.org/0000-0002-7206-2353)
- Biyao Zhang (ORCID: https://orcid.org/0009-0007-0373-8720)
- Lixia Li (ORCID: https://orcid.org/0000-0002-2772-264X)
- Yuye Wu (ORCID: https://orcid.org/0009-0005-5976-0455)
- Jiacheng Yang (ORCID: https://orcid.org/0009-0001-5954-1173)
- Sheng‐Chao Huang
- Shaobo Mo
- Yuzhou Wang
Institutions
- Guangdong Medical College (CN)
- Central People's Hospital of Zhanjiang (CN)
- Affiliated Hospital of Guangdong Medical College Hospital (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2025-11-26
- DOI
- https://doi.org/10.3389/fnut.2025.1688477
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00